Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (741-750 of 962) with videos related to

Pageof 97
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 22, 2018
Head-to-head comparison of the diagnostic performances of Rubidium-PET and SPECT with CZT camera for the detection of myocardial ischemia in a population of women and overweight individualsFabien Hyafil, Renata Chequer, Emmanuel Sorbets, et al.
American Heart Journal|June 15, 2018
Impact of video on the understanding and satisfaction of patients receiving informed consent before elective inpatient coronary angiography: A randomized trialBenoit Lattuca, Nicolas Barber-Chamoux, Benjamin Alos, et al.
Journal of the American Heart Association|September 2, 2017
Self-Reported Health and Outcomes in Patients With Stable Coronary Heart DiseaseRalph A H Stewart, Emil Hagström, Claes Held, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 28, 2023
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US PerspectiveAndre Lamy, John Eikelboom, Wesley Tong, et al.
Stroke|March 15, 2017
Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or StentingCristina Hobeanu, Philippa C Lavallée, Peter M Rothwell, et al.
European Heart Journal|December 14, 2004
DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarctionPhilippe Gabriel Steg, Christophe Thuaire, Dominique Himbert, et al.
Stroke|April 20, 2013
Coronary artery disease and risk of major vascular events after cerebral infarctionPierre Amarenco, Philippa C Lavallée, Julien Labreuche, et al.
The New England Journal of Medicine|September 3, 2019
Ticagrelor in Patients with Stable Coronary Disease and DiabetesP Gabriel Steg, Deepak L Bhatt, Tabassome Simon, et al.
European Heart Journal|July 1, 2011
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of CardiologyPhilippe Gabriel Steg, Kurt Huber, Felicita Andreotti, et al.
International Journal of Cardiology|October 21, 2022
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registryJeremie Abtan, Deepak L Bhatt, Yedid Elbez, et al.
Pageof 97

Showing results (741-750 of 962) with videos related to

Sort By:
Pageof 97
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 22, 2018
Head-to-head comparison of the diagnostic performances of Rubidium-PET and SPECT with CZT camera for the detection of myocardial ischemia in a population of women and overweight individualsFabien Hyafil, Renata Chequer, Emmanuel Sorbets, et al.
American Heart Journal|June 15, 2018
Impact of video on the understanding and satisfaction of patients receiving informed consent before elective inpatient coronary angiography: A randomized trialBenoit Lattuca, Nicolas Barber-Chamoux, Benjamin Alos, et al.
Journal of the American Heart Association|September 2, 2017
Self-Reported Health and Outcomes in Patients With Stable Coronary Heart DiseaseRalph A H Stewart, Emil Hagström, Claes Held, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 28, 2023
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US PerspectiveAndre Lamy, John Eikelboom, Wesley Tong, et al.
Stroke|March 15, 2017
Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or StentingCristina Hobeanu, Philippa C Lavallée, Peter M Rothwell, et al.
European Heart Journal|December 14, 2004
DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarctionPhilippe Gabriel Steg, Christophe Thuaire, Dominique Himbert, et al.
Stroke|April 20, 2013
Coronary artery disease and risk of major vascular events after cerebral infarctionPierre Amarenco, Philippa C Lavallée, Julien Labreuche, et al.
The New England Journal of Medicine|September 3, 2019
Ticagrelor in Patients with Stable Coronary Disease and DiabetesP Gabriel Steg, Deepak L Bhatt, Tabassome Simon, et al.
European Heart Journal|July 1, 2011
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of CardiologyPhilippe Gabriel Steg, Kurt Huber, Felicita Andreotti, et al.
International Journal of Cardiology|October 21, 2022
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registryJeremie Abtan, Deepak L Bhatt, Yedid Elbez, et al.
Pageof 97